This information was published on 2025-07-21T08:19:48 for IP Right Registration Published.
| Field | Value |
| (210) | 2517857 (IR 1835925) |
| (220) |
17 Dec 2024
|
| (300) |
BX, 18 Jun 2024, 1506315
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 1
Chemical products for industry, science and photography, including biochemical products, in particular monoclonal antibodies for scientific in-silico, in-vitro, in-vivo or clinical research and development relating to immuno-oncology. Class 5 Pharmaceutical products, including substances and preparations for human use; biopharmaceutical substances and preparations for human use. Class 42 Medical, scientific and industrial research services; pharmaceutical and biopharmaceutical research and development services; development, research, laboratory analysis and testing of pharmaceutical and biopharmaceutical drugs and for semi-finished products for use in pharmaceuticals; the development of test systems for pharmaceutical and biopharmaceutical products; chemical analysis. Class 44 Medical services; medical and pharmaceutical advisory and consultancy services; medical care services. Class 45 Legal services relating to the exploitation of patents; management and licensing of patents; licensing of intellectual property. |
| (540) | AVC-BOOSTER |
| (550) | Word |
| (730) |
Avidicure IP B.V.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.